X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-28 | NXL | Owens David | Chief Medical Officer | P - Purchase | $2.19 | +500 | 148,293 | 0% | +$1,095 | ||||||
2024-08-13 | NXL | Owens David | Chief Medical Officer | P - Purchase | $0.95 | +1,000 | 147,793 | +1% | +$950 | ||||||
2024-06-28 | NXL | Owens David | Chief Medical Officer | P - Purchase | $1.75 | +1,000 | 146,793 | +1% | +$1,750 | ||||||
2024-06-18 | NXL | Owens David | Chief Medical Officer | P - Purchase | $0.71 | +1,619 | 145,793 | +1% | +$1,149 | ||||||
2024-06-10 | NXL | Owens David | Chief Medical Officer | P - Purchase | $0.64 | +3,000 | 144,174 | +2% | +$1,920 | ||||||
| A | 2022-09-16 | NXL | Morad Rick | Dir | P - Purchase | $4.15 | +2,500 | 170,126 | +1% | +$10,375 | |||||
| A | 2022-09-15 | NXL | White Mark | Pres, CEO | P - Purchase | $4.15 | +25,000 | 309,127 | +9% | +$103,750 | |||||
| A | 2022-09-16 | NXL | Kazden Alan | Dir | P - Purchase | $4.15 | +2,500 | 83,131 | +3% | +$10,375 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |